Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability

Clinical Endocrinology

Volumn 69, Issue 4, 2008, Pages 528-534

  Verhovez, Andrea ^a   Zeoli, Annarita ^b   Williams, Tracy Ann ^a   Morello, Fulvio ^a   Brizzi, Maria Felice ^b   Veglio, Franco ^a   Mulatero, Paolo ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM CHANNEL BLOCKING AGENT; DOXAZOSIN; MINERALOCORTICOID RECEPTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; HUMAN CELL; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENESCENCE; STEM CELL;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; CASE-CONTROL STUDIES; CELL AGING; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PHENOTYPE; RECEPTORS, MINERALOCORTICOID; STEM CELLS;

EID: 51649123958     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03271.x     Document Type: Article

References (29)

1. Mulatero, P., Stowasser, M., Loh, K.C., Fardella, C.E., Gordon, R.D., Mosso, L., Gomez-Sanchez, C.E., Veglio, F. Young, W.F. Jr. (2004) Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. Journal of Clinical Endocrinology and Metabolism, 89, 1045 1050.
2. Milliez, P., Girerd, X., Plouin, P.F., Blacher, J., Safar, M.E. Mourad, J.J. (2005) Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology, 45, 1243 1248.
3. Struthers, A.D. (2004) Aldosterone-induced vasculopathy. Molecular and Cellular Endocrinology, 217, 239 241.
4. Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A. Finkel, T. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New England Journal of Medicine, 348, 593 600.
5. Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., Zeiher, A.M. Dimmeler, S. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circulation Research, 89, E1 E7.
6. Werner, N. Nickenig, G. (2006) Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 257 266.
7. Pirro, M., Schillaci, G., Menecali, C., Bagaglia, F., Paltriccia, R., Vaudo, G., Mannarino, M.R. Mannarino, E. (2007) Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. Journal of Hypertension, 25, 2093 2099.
8. Delva, P., Degan, M., Vallerio, P., Arosio, E., Minuz, P., Amen, G., Di Chio, M. Lechi, A. (2007) Endothelial progenitor cells in patients with essential hypertension. Journal of Hypertension, 25, 127 132.
9. Rosso, A., Balsamo, A., Gambino, R., Dentelli, P., Falcioni, R., Cassader, M., Pegoraro, L., Pagano, G. Brizzi, M.F. (2006) p53 mediates the accelerated onset of senescence of endothelial progenitor cells in diabetes. Journal of Biological Chemistry, 281, 4339 4347.
10. Marumo, T., Uchimura, H., Hayashi, M., Hishikawa, K. Fujita, T. (2006) Aldosterone impairs bone marrow-derived progenitor cell formation. Hypertension, 48, 490 496.
11. Mulatero, P., Veglio, F., Pilon, C., Rabbia, F., Zocchi, C., Limone, P., Boscaro, M., Sonino, N. Fallo, F. (1998) Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. Journal of Clinical Endocrinology and Metabolism, 83, 2573 2575.
12. Mulatero, P., Milan, A., Fallo, F., Regolisti, G., Pizzolo, F., Fardella, C., Mosso, L., Marafetti, L., Veglio, F. Maccario, M. (2006) Comparison of confirmatory tests for the diagnosis of primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 91, 2618 2623.
13. Mulatero, P., Curnow, K.M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P. Pascoe, L. (1998) Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. Journal of Clinical Endocrinology and Metabolism, 83, 3996 4001.
14. Yoder, M.C., Mead, L.E., Prater, D., Krier, T.R., Mroueh, K.N., Li, F., Krasich, R., Temm, C.J., Prchal, J.T. Ingram, D.A. (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood, 109, 1801 1809.
15. Rehman, J., Li, J., Orschell, C.M. March, K.L. (2003) Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation, 107, 1164 1169.
16. Mulatero, P., Milan, A., Williams, T.A. Veglio, F. (2006) Mineralocorticoid receptor blockade in the protection of target organ damage. Cardiovascular and Hematological Agents in Medicinal Chemistry, 4, 75 91.
17. Farquharson, C.A.J. Struthers, A.D. (2000) Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation, 101, 594 597.
18. Leopold, J.A., Dam, A., Maron, B.A., Scribner, A.W., Liao, R., Handy, D.E., Stanton, R.C., Pitt, B. Loscalzo, J. (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nature Medicine, 13, 189 197.
19. Nagata, D., Takahashi, M., Sawai, K., Tagami, T., Usui, T., Shimatsu, A., Hirata, Y. Naruse, M. (2006) Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity. Hypertension, 48, 165 171.
20. Nietlispach, F., Julius, B., Schindler, R., Bernheim, A., Binkert, C., Kiowski, W. Peter Brunner-La Rocca, H. (2007) Influence of acute and chronic mineralocorticoid excess on endothelial function in healthy men. Hypertension, 50, 82 88.
21. Gunaruwan, P., Schmitt, M., Taylor, J., Lee, L., Struthers, A. Frenneaux, M. (2002) Lack of rapid aldosterone effects on forearm resistance vasculature in health. Journal of the Renin-Angiotensin-Aldosterone System, 3, 123 125.
22. Schmidt, B.M., Sammer, U., Fleischmann, I., Schlaich, M., Delles, C. Schmieder, R.E. (2006) Rapid nongenomic effects of aldosterone on the renal vasculature in humans. Hypertension, 47, 650 655.
23. Nishizaka, M.K., Zaman, M.A., Green, S.A., Renfroe, K.Y. Calhoun, D.A. (2004) Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation, 109, 2857 2861.
24. Yoon, C.H., Hur, J., Park, K.W., Kim, J.H., Lee, C.S., Oh, I.Y., Kim, T.Y., Cho, H.J., Kang, H.J., Chae, I.H., Yang, H.K., Oh, B.H., Park, Y.B. Kim, H.S. (2005) Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation, 112, 1618 1627.
25. Assmus, B., Urbich, C., Aicher, A., Hofmann, W.K., Haendeler, J., Rossig, L., Spyridopoulos, I., Zeiher, A.M. Dimmeler, S. (2003) HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circulation Research, 92, 1049 1055.
26. Imanishi, T., Moriwaki, C., Hano, T. Nishio, I. (2005) Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. Journal of Hypertension, 23, 1831 1837.
27. Adrogué, H.J. Madias, N.E. (2007) Sodium and potassium in the pathogenesis of hypertension. New England Journal of Medicine, 356, 1966 1978.
28. Ma, G., Young, D.B., Clower, B.R., Anderson, P.G., Lin, H. Abide, A.M. (2000) High potassium intake inhibits neointima formation in the rat carotid artery balloon injury model. American Journal of Hypertension, 13, 1014 1020.
29. Kido, M., Ando, K., Onorato, M.L., Tojo, A., Yoshikawa, M., Ogita, T. Fujita, T. (2008) Protective effect of dietary potassium against vascular injury in salt-sensitive hypertension. Hypertension, 51, 225 231.